Switch to:
GuruFocus has detected 1 Warning Sign with Cascadian Therapeutics Inc \$CASC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
EV-to-Revenue
(As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, Cascadian Therapeutics Inc's enterprise value is \$144.94 Mil. Cascadian Therapeutics Inc's revenue for the trailing twelve months (TTM) ended in Dec. 2016 was \$0.00 Mil. Therefore, Cascadian Therapeutics Inc's EV/Revenue ratio for today is .

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, Cascadian Therapeutics Inc's stock price is \$4.18. Cascadian Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Dec. 2016 was \$0.00. Therefore, Cascadian Therapeutics Inc's P/S Ratio for today is .

Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cascadian Therapeutics Inc's EV/Revenue for today is calculated as:

 EV/Revenue = Enterprise Value (Today) / Revenue (TTM) = 144.935 / 0 =

Cascadian Therapeutics Inc's current Enterprise Value is \$144.94 Mil.
Cascadian Therapeutics Inc's Revenue for the trailing twelve months (TTM) ended in Dec. 2016 was 0 (Mar. 2016 ) + 0 (Jun. 2016 ) + 0 (Sep. 2016 ) + 0 (Dec. 2016 ) = \$0.00 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cascadian Therapeutics Inc's P/S Ratio for today is calculated as:

 P/S Ratio = Share Price (Today) / Revenue Per Share (TTM) = 4.18 / 0 =

Cascadian Therapeutics Inc's share price for today is \$4.18.
Cascadian Therapeutics Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Dec. 2016 was 0 (Mar. 2016 ) + 0 (Jun. 2016 ) + 0 (Sep. 2016 ) + 0 (Dec. 2016 ) = \$0.00.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.